Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Average Recommendation of “Buy” by Brokerages

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have received a consensus recommendation of “Buy” from the six ratings firms that are currently covering the company, Marketbeat reports. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $12.13.

A number of analysts have commented on BIOX shares. Lake Street Capital reduced their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Roth Mkm decreased their price objective on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Oppenheimer cut their target price on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 21st. Finally, Canaccord Genuity Group decreased their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research report on Wednesday, November 13th.

Bioceres Crop Solutions Trading Down 4.8 %

Shares of NASDAQ:BIOX opened at $6.13 on Monday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27. The stock has a market capitalization of $385.27 million, a price-to-earnings ratio of 306.65 and a beta of 0.49. Bioceres Crop Solutions has a 1-year low of $5.71 and a 1-year high of $14.05. The company has a 50 day moving average price of $7.24 and a 200 day moving average price of $9.52.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The company had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. During the same quarter in the previous year, the firm earned ($0.07) earnings per share. On average, research analysts anticipate that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Stifel Financial Corp increased its holdings in Bioceres Crop Solutions by 33.4% in the third quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after buying an additional 10,224 shares during the last quarter. Fourth Sail Capital LP increased its stake in shares of Bioceres Crop Solutions by 61.6% during the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock worth $24,957,000 after purchasing an additional 1,209,277 shares during the last quarter. Long Focus Capital Management LLC raised its holdings in shares of Bioceres Crop Solutions by 19.9% during the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock valued at $3,145,000 after purchasing an additional 46,647 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after purchasing an additional 5,341 shares during the last quarter. Finally, Ping Capital Management Inc. bought a new stake in Bioceres Crop Solutions in the second quarter worth $448,000. 17.68% of the stock is owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.